| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.41B | 30.13B | 28.64B | 28.85B | 26.93B | 20.99B |
| Gross Profit | 7.15B | 6.49B | 6.14B | 6.07B | 5.34B | 4.13B |
| EBITDA | 1.03B | 872.00M | 999.00M | 1.21B | 909.96M | 231.72M |
| Net Income | 41.00M | 37.00M | 539.00M | 742.00M | 888.86M | 295.12M |
Balance Sheet | ||||||
| Total Assets | 24.77B | 25.83B | 18.46B | 18.55B | 18.66B | 18.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.52B | 4.82B | 3.38B | 2.72B | 2.85B | 2.99B |
| Total Debt | 10.16B | 10.52B | 4.69B | 5.21B | 5.03B | 6.04B |
| Total Liabilities | 17.15B | 17.98B | 10.61B | 11.25B | 11.98B | 12.36B |
| Stockholders Equity | 7.59B | 7.82B | 7.82B | 7.28B | 6.65B | 5.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -178.00M | 1.38B | -115.00M | -257.45M | 312.69M |
| Operating Cash Flow | 0.00 | -96.00M | 1.57B | 68.00M | -152.00M | 330.65M |
| Investing Cash Flow | 0.00 | -2.21B | -3.00M | -235.00M | 1.23B | -268.25M |
| Financing Cash Flow | 0.00 | 3.64B | -849.00M | -103.00M | -1.32B | 631.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥21.89B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
67 Neutral | ¥6.12B | 8.03 | ― | 3.24% | 1.16% | -31.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.74B | -14.04 | ― | 2.05% | -6.69% | -80.28% | |
60 Neutral | ¥6.80B | 5.29 | ― | 3.91% | 21.23% | -112.48% | |
55 Neutral | ¥7.83B | 67.72 | ― | 5.64% | -0.91% | -319.62% | |
54 Neutral | ¥4.60B | 32.98 | ― | 3.60% | -4.75% | -178.90% |